126 related articles for article (PubMed ID: 6428017)
1. Hormonal and receptor status in postmenopausal women with endometrial carcinoma before and after treatment with tamoxifen.
Luciani L; Oriana S; Spatti G; Secreto G; Recchione C; Grignoglio E; Andreola S; Coradini D; Ronchi E; Di Fronzo G
Tumori; 1984 Apr; 70(2):189-92. PubMed ID: 6428017
[TBL] [Abstract][Full Text] [Related]
2. Hormone serum levels and hormone receptor contents of endometria in women with normal menstrual cycles and patients bearing endometrial carcinoma.
Spona J; Ulm R; Bieglmayer C; Husslein P
Gynecol Obstet Invest; 1979; 10(2-3):71-80. PubMed ID: 535775
[TBL] [Abstract][Full Text] [Related]
3. Regression of uterine leiomyomata in response to the antiprogesterone RU 486.
Murphy AA; Kettel LM; Morales AJ; Roberts VJ; Yen SS
J Clin Endocrinol Metab; 1993 Feb; 76(2):513-7. PubMed ID: 8432797
[TBL] [Abstract][Full Text] [Related]
4. Effects of tamoxifen on steroid hormone receptors and hormone concentration and the results of DNA analysis by flow cytometry in endometrial carcinoma.
Nola M; Jukić S; Ilić-Forko J; Babić D; Uzarević B; Petrovecki M; Suchanek E; Skrablin S; Dotlić S; Marusić M
Gynecol Oncol; 1999 Mar; 72(3):331-6. PubMed ID: 10053103
[TBL] [Abstract][Full Text] [Related]
5. Changing estrogen and progesterone receptor patterns in breast carcinoma during the menstrual cycle and menopause.
Pujol P; Daures JP; Thezenas S; Guilleux F; Rouanet P; Grenier J
Cancer; 1998 Aug; 83(4):698-705. PubMed ID: 9708933
[TBL] [Abstract][Full Text] [Related]
6. [The level of steroid hormone receptors in endometrial cancer].
Bieglmayer C; Spona J; Ulm R; Husslein P
Acta Univ Palacki Olomuc Fac Med; 1981; 101():159-65. PubMed ID: 6211045
[No Abstract] [Full Text] [Related]
7. Female sex steroid receptors in normal, hyperplastic and carcinomatous endometrium. The relationship to serum steroid hormones and gonadotropins and changes during medroxyprogesterone acetate administration.
Jänne O; Kauppila A; Kontula K; Syrjälä P; Vihko R
Int J Cancer; 1979 Nov; 24(5):545-54. PubMed ID: 231013
[No Abstract] [Full Text] [Related]
8. Hormone steroid receptor variation after tamoxifen administration in endometrial adenocarcinoma from postmenopausal patients.
Di Fronzo G; Ronchi E; Cappelletti V; Luciani L; Coradini D; Oriana S; Miodini P; Andreola S
Cancer Detect Prev; 1986; 9(3-4):323-30. PubMed ID: 3742507
[TBL] [Abstract][Full Text] [Related]
9. Hormonal aspects of endometrial cancer.
Sutton G
Curr Opin Obstet Gynecol; 1990 Feb; 2(1):69-73. PubMed ID: 2102309
[TBL] [Abstract][Full Text] [Related]
10. Variation of estrogen and progesterone receptor status in breast cancer after tamoxifen therapy.
Melchor JC; Rodríguez-Escudero FJ; Luján S; Corcóstegui B
Oncology; 1990; 47(6):467-70. PubMed ID: 2123023
[TBL] [Abstract][Full Text] [Related]
11. Endocrine effects of adjuvant letrozole compared with tamoxifen in hormone-responsive postmenopausal patients with early breast cancer: the HOBOE trial.
Rossi E; Morabito A; Di Rella F; Esposito G; Gravina A; Labonia V; Landi G; Nuzzo F; Pacilio C; De Maio E; Di Maio M; Piccirillo MC; De Feo G; D'Aiuto G; Botti G; Chiodini P; Gallo C; Perrone F; de Matteis A
J Clin Oncol; 2009 Jul; 27(19):3192-7. PubMed ID: 19380451
[TBL] [Abstract][Full Text] [Related]
12. The endometrial adenocarcinoma as a model for hormone-dependency and hormone-responsiveness of gynaecological cancers.
Bonte J
Eur J Obstet Gynecol Reprod Biol; 1984 Dec; 18(5-6):335-41. PubMed ID: 6526120
[TBL] [Abstract][Full Text] [Related]
13. Pituitary-ovarian relationships preceding the menopause. I. A cross-sectional study of serum follice-stimulating hormone, luteinizing hormone, prolactin, estradiol, and progesterone levels.
Reyes FI; Winter JS; Faiman C
Am J Obstet Gynecol; 1977 Nov; 129(5):557-64. PubMed ID: 910845
[TBL] [Abstract][Full Text] [Related]
14. [Response to an antiestrogen as a criterion for hormonal sensitivity of endometrial cancer].
Robel P; Lévy C; Wolff JP; Nicolas JC; Baulieu EE
C R Acad Hebd Seances Acad Sci D; 1978 Nov; 287(15):1353-6. PubMed ID: 111815
[TBL] [Abstract][Full Text] [Related]
15. Female sex steroid receptor status in primary and metastatic breast carcinoma and its relationship to serum steroid peptide hormone levels.
Vihko R; Jänne O; Kontula K; Syrjälä P
Int J Cancer; 1980 Jul; 26(1):13-21. PubMed ID: 6786991
[No Abstract] [Full Text] [Related]
16. Neoadjuvant chemotherapy modifies serum pyrrolidone carboxypeptidase specific activity in women with breast cancer and influences circulating levels of GnRH and gonadotropins.
Ramírez-Expósito MJ; Martínez-Martos JM; Dueñas-Rodríguez B; Navarro-Cecilia J; Carrera-González MP
Breast Cancer Res Treat; 2020 Aug; 182(3):751-760. PubMed ID: 32506336
[TBL] [Abstract][Full Text] [Related]
17. [Hormonal status of patients with uterine cancer during surgical treatment].
Musina RKh; Kiseleva NS; Modnikov OP
Vopr Onkol; 1987; 33(8):99-102. PubMed ID: 2820150
[TBL] [Abstract][Full Text] [Related]
18. A prospective prognostic study of the hormonal milieu at the time of surgery in premenopausal breast carcinoma.
Pujol P; Daures JP; Brouillet JP; Chang S; Rouanet P; Bringer J; Grenier J; Maudelonde T
Cancer; 2001 May; 91(10):1854-61. PubMed ID: 11346866
[TBL] [Abstract][Full Text] [Related]
19. Tamoxifen in the therapy of post-menopausal endometrial cancer: variations in some hormonal parameters.
Marchesoni D; Mozzanega B; Gangemi M; Enrichi M
Eur J Gynaecol Oncol; 1980 May; 1(2):116-21. PubMed ID: 6800794
[No Abstract] [Full Text] [Related]
20. Identification of endocrine responsive breast and endometrial carcinoma using steroid hormone receptors.
Wittliff JL; Day TG; Dean WL; Allegra JC
Prog Clin Biol Res; 1988; 276():11-41. PubMed ID: 3051018
[No Abstract] [Full Text] [Related]
[Next] [New Search]
